Other side-effects such as cognitive decline, visual hallucinations and daytime sleepiness have been implicated in various polymorphisms of the COMT, DRD2, DRD3, HOMER1 and BDNF genes, but lack consistency in the results to consider current clinical implementations. The gene discussed is DRD3; the disease is Mental deterioration.